US EditionEvernorth expanding GLP-1 presence with EnReachRx – RamaOnHealthcare
Summary by ramaonhealthcare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Evernorth expanding GLP-1 presence with EnReachRx – RamaOnHealthcare
EnReachRx includes dose optimization support, as well as enhanced fraud, waste and abuse detection and interventions.Cigna's Evernorth is signaling that it will expand its GLP-1 medication offerings through the creation of Evernorth EnReachRx, a new patient support model for pharmacies that want to provide enhanced clinical services alongside the GLP-1 drugs.As part of EnReachRx, Evernorth [...]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
